|
CN111132665A
|
|
Pharmaceutical composition and preparation method thereof
|
|
CN102666530A
|
|
Imatinib dichloroacetate and anti-cancer agent comprising the same
|
|
KR20120010008A
|
|
L-Carnitine 1,5-naphthalenedisulfonate and pharmaceutical composition comprising the same
|
|
KR20120007848A
|
|
Erlotinib dichloroacetate and anti-cancer agent comprising the same
|
|
EP2445895A2
|
|
Piperazine dithioctate and pharmaceutical composition comprising the same
|
|
KR20110138040A
|
|
Crystalline form of donepezil base and process for preparing the same
|
|
KR20110132017A
|
|
Pharmaceutical composition comprising piperazine dithioctate and glimepiride
|
|
KR20110132010A
|
|
Acetyl-l-carnitine malate, process for preparing the same, and pharmaceutical composition comprising the same
|
|
KR20100136407A
|
|
Adefovir dipivoxil hemisebacate and pharmaceutical composition comprising the same
|
|
KR20110095545A
|
|
(s)-rivastigmine orotate and pharmaceutical composition including the same
|
|
KR20110019145A
|
|
Method of preparing (s)-rivastigmine
|
|
KR100971486B1
|
|
Adefovir dipivoxil malonate and pharmaceutical composition including the same
|
|
KR20100125567A
|
|
Pharmaceutical composition comprising sibutramin and tioctic acid
|
|
KR20100111431A
|
|
Crystalline forms of anhydrous docetaxel and process for preparing the same
|
|
KR20100097264A
|
|
Amlodipine-losartan disulfonate, process for preparing the same, and pharmaceutical composition including the same
|
|
KR20100091630A
|
|
Adefovir dipivoxil-l-carnitine disulfonate, process for preparing the same, and pharmaceutical composition including the same
|
|
KR20100074575A
|
|
Sibutramine-l-carnitine disulfonate, process for preparing the same, and pharmaceutical composition including the same
|
